These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28326369)

  • 1. The effect of new oral anticoagulants and extended thromboprophylaxis policy on hip and knee arthroplasty outcomes: observational study.
    Bottle A; Oragui E; Pinder E; Aylin P; Loeffler M
    Arthroplast Today; 2015 Jun; 1(2):45-50. PubMed ID: 28326369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
    Forster R; Stewart M
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Effectiveness of Aspirin as Multimodal Thromboprophylaxis in Primary Total Hip and Knee Arthroplasty: A Review of 6078 Cases.
    Ghosh A; Best AJ; Rudge SJ; Chatterji U
    J Arthroplasty; 2019 Jul; 34(7):1359-1363. PubMed ID: 30982759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative Thromboprophylaxis With New Oral Anticoagulants is Superior to LMWH in Hip Arthroplasty Surgery: Findings from the Swedish Registry.
    Kasina P; Wall A; Lapidus LJ; Rolfson O; Kärrholm J; Nemes S; Eriksson BI; Mohaddes M
    Clin Orthop Relat Res; 2019 Jun; 477(6):1335-1343. PubMed ID: 31136431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
    Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
    Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous Thromboembolism in Total Hip and Total Knee Arthroplasty.
    Simon SJ; Patell R; Zwicker JI; Kazi DS; Hollenbeck BL
    JAMA Netw Open; 2023 Dec; 6(12):e2345883. PubMed ID: 38039005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wound Discharge After Pharmacological Thromboprophylaxis in Lower Limb Arthroplasty.
    Jones CW; Spasojevic S; Goh G; Joseph Z; Wood DJ; Yates PJ
    J Arthroplasty; 2018 Jan; 33(1):224-229. PubMed ID: 28869115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements.
    Nielen JT; Dagnelie PC; Emans PJ; Veldhorst-Janssen N; Lalmohamed A; van Staa TP; Boonen AE; van den Bemt BJ; de Vries F
    Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1245-1252. PubMed ID: 27594378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996-2001: findings from the Hip and Knee Registry.
    Anderson FA; Hirsh J; White K; Fitzgerald RH;
    Chest; 2003 Dec; 124(6 Suppl):349S-356S. PubMed ID: 14668417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective hip and knee arthroplasty and the effect of rivaroxaban and enoxaparin thromboprophylaxis on wound healing.
    Sindali K; Rose B; Soueid H; Jeer P; Saran D; Shrivastava R
    Eur J Orthop Surg Traumatol; 2013 May; 23(4):481-6. PubMed ID: 23412293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of thromboprophylaxis guidelines on clinical outcomes following total hip and total knee replacement.
    Selby R; Borah BJ; McDonald HP; Henk HJ; Crowther M; Wells PS
    Thromb Res; 2012 Aug; 130(2):166-72. PubMed ID: 22365491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors and distribution of symptomatic venous thromboembolism in total hip and knee replacements: prospective study.
    Markovic-Denic L; Zivkovic K; Lesic A; Bumbasirevic V; Dubljanin-Raspopovic E; Bumbasirevic M
    Int Orthop; 2012 Jun; 36(6):1299-305. PubMed ID: 22215369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Similar Clinical Outcomes with Preoperative and Postoperative Start of Thromboprophylaxis in THA: A Register-based Study.
    Borgen PO; Pripp AH; Dybvik E; Leistad L; Dahl OE; Reikerås O
    Clin Orthop Relat Res; 2017 Sep; 475(9):2245-2252. PubMed ID: 28643079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism rates in patients undergoing major hip and knee joint surgery at Waitemata District Health Board: a retrospective audit.
    Dixon J; Ahn E; Zhou L; Lim R; Simpson D; Merriman EG
    Intern Med J; 2015 Apr; 45(4):416-22. PubMed ID: 25644232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.
    Senay A; Trottier M; Delisle J; Banica A; Benoit B; Laflamme GY; Malo M; Nguyen H; Ranger P; Fernandes JC
    Vasc Health Risk Manag; 2018; 14():81-89. PubMed ID: 29780248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
    Ní Cheallaigh S; Fleming A; Dahly D; Kehoe E; O'Byrne JM; McGrath B; O'Connell C; Sahm LJ
    Int J Clin Pharm; 2020 Jun; 42(3):853-860. PubMed ID: 32328957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the first-generation AAOS clinical guidelines on the prophylaxis of venous thromboembolic events in patients undergoing total joint arthroplasty: experience with 3289 patients from a single institution.
    Lewis CG; Inneh IA; Schutzer SF; Grady-Benson J
    J Bone Joint Surg Am; 2014 Aug; 96(16):1327-32. PubMed ID: 25143492
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.